Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. - Wikidata - awgldk - TriplyDB

Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.

Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.

http://www.wikidata.org/entity/Q35848872

about

Understanding of molecular mechanisms in natural killer cell therapy NK cells in therapy of cancer TOX2 regulates human natural killer cell development by controlling T-BET expression Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.Human natural killer cell development in secondary lymphoid tissues Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.Immunotherapy for pediatric cancer.CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.Natural killer-cell differentiation by myeloid progenitors Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT)Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.Generation of CD2(+)CD8(+) NK Cells from c-kit(+) Bone Marrow Cells in Porcine 'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammation A Reproducible Method for Isolation and In Vitro Culture of Functional Human Lymphoid Stromal Cells from Tonsils Donor major histocompatibility complex class I expression determines the outcome of prenatal transplantation.NKp80 Defines a Critical Step during Human Natural Killer Cell Development.Immature NK cells, capable of producing IL-22, are present in human uterine mucosa Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia Location and cellular stages of natural killer cell development.Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy.In vivo generation of decidual natural killer cells from resident hematopoietic progenitors.Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin-CD34+DNAM-1brightCXCR4+ Cell Progenitor.Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells.Roles and mechanism of natural killer cells in clinical and experimental transplantation.Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL.Clinical utility of natural killer cells in cancer therapy and transplantation.Deferasirox nephrotoxicity-the knowns and unknowns.Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells.Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation.

P2860

Q28086976-C51EA21B-41FC-4A55-BA55-49E0FAC3E325 Q28242241-6755172B-7174-4F47-9CA6-5F4D9CBF7DBB Q28854590-B61689FA-7833-4B8F-8E7E-9B1C724238AE Q30437635-7D61DB62-9613-4F5C-9860-98BB61E162EC Q33567199-A4817368-1207-4313-9D0A-20DA23C93F9E Q33789537-C83B403C-A9B8-4B51-B69A-4E280B96D3F1 Q33924586-A8EC2D00-4AB6-4B7F-9E62-67B3E2C31F25 Q34572976-B3937F99-8A93-494B-9D25-4E9B53915EC3 Q34773999-D1CA23FC-A68D-42C6-B249-7EF6384C1F1B Q34839054-89F23C8F-87F0-4A60-92CE-A384ADD1656C Q34924388-44A79DA9-3F87-4950-931D-251E07CA5A80 Q35212365-442532E7-200B-4429-A498-02245BE3DBA8 Q35830835-35D5E5A2-DD4B-45A0-939D-55CDE6A5017F Q35909663-DA2ADA5A-C04C-4917-A532-B76A14EC487B Q36089776-AE6B7FE3-7384-4513-BBF8-BB2922CC06FD Q36145878-ED7D9000-B288-4120-A7B0-9BCA6F690FF4 Q36210450-E35039DD-3DEA-4368-8545-CBC59816530D Q36983165-37ABFDE5-7D04-4010-B3E6-FFBEC40D9D1E Q37145726-FBDA2397-1F0B-459C-8567-684FD54016F5 Q37226619-4C9333C1-1A28-4335-B8BD-AD5CE14D9062 Q37234607-31A971F1-B1D6-4DF7-A9D1-9DD3AA0F2208 Q37343462-606178EF-6D9A-4352-8439-C674E0954713 Q37366117-D5161DC6-446F-418D-8178-16CB0775C09F Q37398305-16B09B4B-B3EB-4407-9DB4-181128C6FBDD Q37569278-1F9BCEA4-E910-424E-AA2D-A23EB6A02CDF Q37589671-F4DB7602-F9B4-43FD-BDB0-6348CC264EB5 Q37606560-3C6ECA6D-A4DC-400E-8BB3-5E7DC8F84954 Q37616324-B457761F-DF50-4CFB-A67D-503D8AD1AC9D Q37618891-F39CE489-910B-4CB5-94EF-23DD47CF8C79 Q37689426-BEB3B70E-DBD5-45D6-8BF0-011E32FA9B4B Q37721588-5457B5AF-CAC1-441C-BEC3-83639257710B Q37755212-A5080A52-7837-4811-A08B-AEBB4BF0E9D6 Q38019320-A7BA3634-8C73-4261-95F0-7EFFF8A39A6B Q38151057-2BB126A7-2719-48C0-9232-0E571EB2FF9A Q38169654-524FC861-CBD7-45B1-B899-CCCF28066335 Q38195120-2C1C8DD8-A5FC-4A73-8FEA-13EA5AF6985B Q38232442-56772270-2A6A-4DE4-B105-9AEF33EE3B78 Q38292676-74C51F32-F252-4098-AF65-94A0CD0EB11D Q38365989-8245B3D6-1E70-4933-83A0-AFF7C27D2235 Q38410880-3CC8FC27-8DAD-4EB9-8181-EA6F81BF3F0C

P2860

Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.

http://www.wikidata.org/entity/Q35848872

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Coordinated acquisition of inh ...... ng human natural killer cells.

@ast

Coordinated acquisition of inh ...... ng human natural killer cells.

@en

type

label

Coordinated acquisition of inh ...... ng human natural killer cells.

@ast

Coordinated acquisition of inh ...... ng human natural killer cells.

@en

prefLabel

Coordinated acquisition of inh ...... ng human natural killer cells.

@ast

Coordinated acquisition of inh ...... ng human natural killer cells.

@en

P1433

Q35848872-EAA79C83-2DDF-4A8B-871B-3F218F0D9E02

P1476

Q35848872-81EEB9DE-1735-43E4-9C72-DD9405C1BEA1

P2093

Q35848872-4EF7681B-6096-4310-BE1E-2002E917A629

Q35848872-785BB01F-D8FB-42F5-8D9E-D9447042612C

Q35848872-9A1151BA-2AD7-4C46-8DFE-3FDAE804A42E

Q35848872-AE83CE19-36AC-48B7-BF35-F2A3B9B30F05

Q35848872-CCD6788D-9E25-4CEB-A96B-3054DDD62222

Q35848872-F679346B-76ED-4368-A2C3-9642ADEC7919

P2860

Q35848872-01BA8370-93E9-4AD4-9094-C048C79268C9

Q35848872-0C09A41C-2BA3-4057-8FD7-3897EC7EE4AE

Q35848872-118B35C3-55EA-4280-B746-2B00FF09E69F

Q35848872-14905862-D697-43F8-84E0-E86EC8055267

Q35848872-1A2D4964-C965-44A7-8456-9F366647C6F4

Q35848872-1B9A0581-DFBF-4506-A6F5-3504A0FE5888

Q35848872-2709D3C7-2779-43CA-8B00-ED8834A73610

Q35848872-2DF2DB52-CCD6-4170-8CBD-DAAD5DA63386

Q35848872-32F33F67-BB66-4335-9F87-6653321399F6

Q35848872-3BD84440-7885-4881-9B65-56DE50701AE6

P304

Q35848872-7A96BC77-351B-4E5A-A154-C8AFBDBDA05D

P31

Q35848872-164785CB-1F68-44FC-A02B-19E237AF9741

P356

Q35848872-DC980C02-F806-4CA9-9449-3897B189A021

P407

Q35848872-9C02E9C7-2C55-4907-AD03-810D7640FE7E

P433

Q35848872-AF710B82-15C1-4074-91C1-7FB98B5E9943

P478

Q35848872-F4530C08-68B7-41C4-B9C1-46FA038CA014

P50

Q35848872-8F9F7B9D-FAC8-4737-8D51-98848F283ECB

Q35848872-AA4816B3-89DB-4250-B121-9E8E8FD99124

P577

Q35848872-9308232C-8956-4AF4-BFFA-D461AA6F7507

P5875

Q35848872-9BB90DB1-7ECA-417C-B5FB-DE80B53DBA18

P698

Q35848872-1B411A9E-09F4-407E-ACDC-68AE0E1CF877

P932

Q35848872-D34706E2-FF62-4530-B4FA-1C8F89218A45

P356

BLOOD-2006-04-020198

P1433

P1476

Coordinated acquisition of inh ...... ing human natural killer cells

@en

P2093

Bartosz Grzywacz

http://www.w3.org/2001/XMLSchema#string

Bruce R Blazar

http://www.w3.org/2001/XMLSchema#string

Elaine A Dzierzak

http://www.w3.org/2001/XMLSchema#string

Magdalena Sikora

http://www.w3.org/2001/XMLSchema#string

Michael R Verneris

http://www.w3.org/2001/XMLSchema#string

Nandini Kataria

http://www.w3.org/2001/XMLSchema#string

P2860

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily

Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor

Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation.

CD34+ cells cultured in stem cell factor and interleukin-2 generate CD56+ cells with antiproliferative effects on tumor cell lines.

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors

Human diversity in killer cell inhibitory receptor genes

Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

Biology of natural killer cells

P304

3824-3833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2006-04-020198

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey S. Miller

Robert Oostendorp

P577

2006-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6885482

http://www.w3.org/2001/XMLSchema#string

P698

16902150

http://www.w3.org/2001/XMLSchema#string

P932

1895469

http://www.w3.org/2001/XMLSchema#string